These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1854163)

  • 1. Mercuric reductase activity and evidence of broad-spectrum mercury resistance among clinical isolates of rapidly growing mycobacteria.
    Steingrube VA; Wallace RJ; Steele LC; Pang YJ
    Antimicrob Agents Chemother; 1991 May; 35(5):819-23. PubMed ID: 1854163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibilities of Mycobacterium fortuitum biovariant fortuitum and the unnamed third biovariant complex to heavy-metal salts.
    Wallace RJ; Steele LC; Forrester GD; Swenson JM; Hull SI
    Antimicrob Agents Chemother; 1984 Oct; 26(4):594-6. PubMed ID: 6517549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy.
    Wallace RJ; Bedsole G; Sumter G; Sanders CV; Steele LC; Brown BA; Smith J; Graham DR
    Antimicrob Agents Chemother; 1990 Jan; 34(1):65-70. PubMed ID: 2327761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial resistances to inorganic mercury salts and organomercurials.
    Misra TK
    Plasmid; 1992 Jan; 27(1):4-16. PubMed ID: 1311113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free mercury volatilization activity from three marine caulobacter strains.
    Ji GY; Salzberg SP; Silver S
    Appl Environ Microbiol; 1989 Feb; 55(2):523-5. PubMed ID: 2655538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mercury resistance determined by a self-transmissible plasmid in Bacillus cereus 5.
    Belliveau BH; Trevors JT
    Biol Met; 1990; 3(3-4):188-96. PubMed ID: 2127369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China.
    Pang H; Li G; Zhao X; Liu H; Wan K; Yu P
    Biomed Res Int; 2015; 2015():419392. PubMed ID: 26351633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoelectric focusing patterns of beta-lactamases in the rapidly growing mycobacteria.
    Zhang Y; Wallace RJ; Steingrube VA; Brown BA; Nash R; Silcox A; Tsukamura M
    Tuber Lung Dis; 1992 Dec; 73(6):337-44. PubMed ID: 1292713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel.
    Cavusoglu C; Gurpinar T; Ecemis T
    New Microbiol; 2012 Jan; 35(1):73-6. PubMed ID: 22378556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria.
    Steingrube VA; Gibson JL; Brown BA; Zhang Y; Wilson RW; Rajagopalan M; Wallace RJ
    J Clin Microbiol; 1995 Jan; 33(1):149-53. PubMed ID: 7699032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility.
    Uslan DZ; Kowalski TJ; Wengenack NL; Virk A; Wilson JW
    Arch Dermatol; 2006 Oct; 142(10):1287-92. PubMed ID: 17043183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae.
    Aono A; Morimoto K; Chikamatsu K; Yamada H; Igarashi Y; Murase Y; Takaki A; Mitarai S
    J Infect Chemother; 2019 Feb; 25(2):117-123. PubMed ID: 30447882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms.
    Brown BA; Wallace RJ; Onyi GO; De Rosas V; Wallace RJ
    Antimicrob Agents Chemother; 1992 Jan; 36(1):180-4. PubMed ID: 1317144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mercury and organomercurial resistances determined by plasmids in Staphylococcus aureus.
    Weiss AA; Murphy SD; Silver S
    J Bacteriol; 1977 Oct; 132(1):197-208. PubMed ID: 914774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mercury operon regulation by the merR gene of the organomercurial resistance system of plasmid pDU1358.
    Nucifora G; Chu L; Silver S; Misra TK
    J Bacteriol; 1989 Aug; 171(8):4241-7. PubMed ID: 2666393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mercuric reductase in environmental gram-positive bacteria sensitive to mercury.
    Bogdanova ES; Mindlin SZ; Pakrová E; Kocur M; Rouch DA
    FEMS Microbiol Lett; 1992 Oct; 76(1-2):95-100. PubMed ID: 1427009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility testing of rapidly growing mycobacteria by microdilution - experience of a tertiary care centre.
    Set R; Rokade S; Agrawal S; Shastri J
    Indian J Med Microbiol; 2010; 28(1):48-50. PubMed ID: 20061764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of ciprofloxacin but not pipemidic acid to differentiate all three biovariants of Mycobacterium fortuitum from Mycobacterium chelonae.
    Steele LC; Wallace RJ
    J Clin Microbiol; 1987 Feb; 25(2):456-7. PubMed ID: 3818939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance of rapidly growing mycobacteria in western Taiwan: SMART program 2002.
    Huang TS; Lee SS; Hsueh PR; Tsai HC; Chen YS; Wann SR; Leu HS; Ko WC; Yan JJ; Yuan SZ; Chang FY; Lu JJ; Wang JH; Wang HK; Liu YC
    J Formos Med Assoc; 2008 Apr; 107(4):281-7. PubMed ID: 18445541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic reduction of mercurous and mercuric ions in Bacillus cereus.
    Izaki K
    Can J Microbiol; 1981 Feb; 27(2):192-7. PubMed ID: 6452192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.